BME Growth welcomes Labiana Health

From left to the right: Manuel Ramos Ortega CEO and Todor Velev CFO, of Labiana during the Bell Ringing

• It becomes the fourth company to join this BME market in 2022

BME Growth today welcomed LABIANA HEALTH. The Bell Ringing, which was held at the Madrid stock exchange, was led by Manuel Ramos Ortega, CEO of the company, who was accompanied by Jesús González Nieto-Márquez, General Manager of BME Growth.

The company, which is the fourth to join this BME market so far this year, set a reference price of 5 euros, bringing the company's initial valuation to 36.1 million euros.

"The arrival of Labiana Health to BME Growth is great news for the company, which will be able to finance its future growth in this BME market, and also for investors, who have been showing a growing interest in the pharmaceutical and healthcare sector for some time. With its incorporation, the SME Growth market now shows a more diversified and broadly represented Spanish business fabric," said Jesús González Nieto-Márquez, General Manager of BME Growth.

The company began trading under the trading code "LAB".

All photos of LABIANA HEALTH’s bell ringing are available on Flickr through this link:

https://www.flickr.com/photos/archivobme/